Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling an...
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel
About this item
Full title
Author / Creator
Labanca, Estefania , Bizzotto, Juan , Sanchis, Pablo , Anselmino, Nicolas , Yang, Jun , Shepherd, Peter D. A. , Paez, Alejandra , Antico-Arciuch, Valeria , Lage-Vickers, Sofia , Hoang, Anh G. , Tang, Ximing , Raso, Maria Gabriela , Titus, Mark , Efstathiou, Eleni , Cotignola, Javier , Araujo, John , Logothetis, Christopher , Vazquez, Elba , Navone, Nora and Gueron, Geraldine
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Prostate cancer (PCa) that progresses after androgen deprivation therapy (ADT) remains incurable. The underlying mechanisms that account for the ultimate emergence of resistance to ADT, progressing to castrate-resistant prostate cancer (CRPC), include those that reactivate androgen receptor (AR), or those that are entirely independent or cooperate...
Alternative Titles
Full title
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel
Authors, Artists and Contributors
Author / Creator
Bizzotto, Juan
Sanchis, Pablo
Anselmino, Nicolas
Yang, Jun
Shepherd, Peter D. A.
Paez, Alejandra
Antico-Arciuch, Valeria
Lage-Vickers, Sofia
Hoang, Anh G.
Tang, Ximing
Raso, Maria Gabriela
Titus, Mark
Efstathiou, Eleni
Cotignola, Javier
Araujo, John
Logothetis, Christopher
Vazquez, Elba
Navone, Nora
Gueron, Geraldine
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8566229
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8566229
Other Identifiers
ISSN
0950-9232
E-ISSN
1476-5594
DOI
10.1038/s41388-021-02008-9
